- Home
- IPSC vs CRNT Comparison
IPSC vs CRNT Comparison
Compare IPSC & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPSC | CRNT |
|---|---|---|
| Founded | 2019 | 1996 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.7M | 189.7M |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | IPSC | CRNT |
|---|---|---|
| Price | $2.36 | $2.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $3.50 | ★ $4.00 |
| AVG Volume (30 Days) | ★ 1.0M | 377.3K |
| Earning Date | 06-16-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $109,164,000.00 | N/A |
| Revenue This Year | N/A | $9.32 |
| Revenue Next Year | N/A | $6.43 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1556.76 | N/A |
| 52 Week Low | $0.34 | $1.82 |
| 52 Week High | $2.97 | $2.84 |
Technical Indicators
Market Signals| Indicator | IPSC | CRNT |
|---|---|---|
| Relative Strength Index (RSI) | 52.44 | 45.76 |
| Support Level | $0.49 | $2.05 |
| Resistance Level | $2.71 | $2.38 |
| Average True Range (ATR) | 0.24 | 0.08 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 28.90 | 25.16 |
Price Performance
Historical ComparisonAbout IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.